Soen, Satoshi
Kishimoto, Hideaki
Hagino, Hiroshi
Sone, Teruki
Ohishi, Hiroaki
Fujimoto, Tsukasa
Sasaki, Emma
Tanaka, Sakae
Sugimoto, Toshitsugu
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Received: 27 February 2019
Accepted: 26 June 2019
First Online: 16 August 2019
Compliance with ethical standards
:
: S.S. has received grants/research support from Daiichi-Sankyo, Eisai, and Takeda; and is a member of speaker’s bureaus for Asahi Kasei, Astellas Pharma, Chugai, Daiichi-Sankyo, Eisai, Merck Sharp & Dohme, Ono, Pfizer, Takeda, and Teijin Pharma. H.K. has received consulting fees from Asahi Kasei Pharma, Daiichi-Sankyo, Chugai Pharmaceutical, and Eli Lilly Japan. H.H. has received grants/research support or lecture fees from Asahi Kasei Pharma, Astellas Pharma, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly Japan, Mitsubishi Tanabe, Merck Sharp & Dohme, Ono, Pfizer, Taisho Toyama Pharmaceutical, Takeda, and Teijin Pharma. T.So. has received research grants from Asahi Kasei Pharma, Astellas Pharma, Daiichi-Sankyo, Pfizer, Taisho Toyama Pharmaceutical, Takeda, and Teijin Pharma; and has received consulting fees from Daiichi-Sankyo and Takeda. H.O. is an employee of EA Pharma. T.F. and E.S. are employees of Takeda Pharmaceutical. S.T. has been a consultant and received honoraria from Eisai, given expert testimony for Takeda Pharmaceutical and EA Pharma, undertaken contracted research for EA Pharma, and received endowments from Takeda Pharmaceutical. T.Su. has received research grants from Astellas Pharma, Eisai, Daiichi-Sankyo, Chugai Pharmaceutical, and Eli Lilly Japan as well as consulting and/or lecture fees from Asahi Kasei Pharma and Daiichi-Sankyo.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients provided written, informed consent. Trial registration: ClinicalTrials.gov number NCT02063854.